Reaction Details | |||
---|---|---|---|
Report a problem with these data | |||
Target | Tyrosine-protein kinase receptor UFO | ||
Ligand | BDBM50444261 | ||
Substrate/Competitor | n/a | ||
Meas. Tech. | ChEMBL_1277931 (CHEMBL3094775) | ||
IC50 | >30000±n/a nM | ||
Citation | Zhang, W; McIver, AL; Stashko, MA; DeRyckere, D; Branchford, BR; Hunter, D; Kireev, D; Miley, MJ; Norris-Drouin, J; Stewart, WM; Lee, M; Sather, S; Zhou, Y; Di Paola, JA; Machius, M; Janzen, WP; Earp, HS; Graham, DK; Frye, SV; Wang, X Discovery of Mer specific tyrosine kinase inhibitors for the treatment and prevention of thrombosis. J Med Chem56:9693-700 (2014) [PubMed] Article | ||
More Info.: | Get all data from this article, Assay Method | ||
Tyrosine-protein kinase receptor UFO | |||
Name: | Tyrosine-protein kinase receptor UFO | ||
Synonyms: | AXL | AXL oncogene | TEL/AXL | Tyrosine-protein kinase receptor UFO (AXL) | UFO | UFO_HUMAN | ||
Type: | Enzyme | ||
Mol. Mass.: | 98316.97 | ||
Organism: | Homo sapiens (Human) | ||
Description: | P30530 | ||
Residue: | 894 | ||
Sequence: |
| ||
BDBM50444261 | |||
n/a | |||
Name | BDBM50444261 | ||
Synonyms: | CHEMBL3093765 | ||
Type | Small organic molecule | ||
Emp. Form. | C22H31FN6O | ||
Mol. Mass. | 414.5195 | ||
SMILES | CCCCNc1ncc(NC(=O)c2ccc(F)cc2)c(NC[C@H]2CC[C@H](N)CC2)n1 |r,wU:22.22,wD:25.26,(18,-11.88,;19.34,-11.11,;20.67,-11.89,;22.01,-11.12,;23.34,-11.89,;24.67,-11.12,;26.01,-11.89,;27.35,-11.12,;27.34,-9.57,;28.67,-8.79,;30.01,-9.56,;30.01,-11.1,;31.34,-8.78,;32.67,-9.55,;34,-8.78,;34,-7.24,;35.33,-6.46,;32.65,-6.47,;31.33,-7.25,;26,-8.8,;26,-7.26,;24.66,-6.5,;24.66,-4.96,;23.33,-4.2,;23.33,-2.65,;24.67,-1.88,;24.67,-.34,;26,-2.65,;26,-4.19,;24.68,-9.57,)| | ||
Structure |